Brain penetration and neurological effects of gadobenate dimeglumine in the rat

References

• Cavagna D., Maggioni F., Castelli P. M., Vicinanza E., Marzola P., Dapra M. Weak binding of Gd-bopta/dimeg to extravasated serum protein enhances conspicuity of brain tumors in rats. Radiology 1994; 193 (P): 210
   Google Scholar
• Davies A., De Haen C. Gadobenic acid dimeglumine salt. Drugs Fut. 1991; 16: 1001
   Google Scholar
• Dunham N. W., Miya T. S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 1957; 46: 208
   Google Scholar
• Felder E., Uggeri F., Fumagalli L., Vittadini G. (Bracco Industria Chimica SpA, Milan, Italy): Paramagnetic chelates useful for NMR imaging. Patent U. S. 4,916,246 (CO7F13/00; 556/1), 30 January, 1986, 10 April, 1990, IT 19236A/86
   Google Scholar
• Gallucci M., Aprile I., Cardone G. P., Di Renzi P., Migliori O., Passariello R. Diagnostic value of Gdbopta, a new contrast agent for the study of intracranial tumors. Preliminary results in comparison with Gd-DTPA. Neuroradiology 1992; 34(Suppl.)31
   Google Scholar
• Jeffers W. A., Griffith J. Q. The rat in laboratory investigation. Lippincott, Philadelphia 1949; 196
   Google Scholar
• Johansson B. B. Hypertension and the blood-brain barrier. Implications of the blood-brain barrier and its manipulation, E. A. Neuwelt. Plenum Press, New York 1989; vol. 2: 389
   Google Scholar
• Larsson H., Stubgaard M., Fredriksen J., Jensen M., Henriksen O., Paulson O. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium Dtpa in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 1990; 16: 117
   PubMed Web of Science ®Google Scholar
• Maggioni F., Castelli P. M., Marzola P., et al. Magnetization transfer MR imaging of experimental rat brain tumorswith Gd-bopta/dimeglumine and Gd-dtpa/dimeglumine. Radiology 1995; 197(P): 149
   Web of Science ®Google Scholar
• Merck E. Complexometric assay methods with Titriplexr`. E. Merck, DarmstadtGermany 1982
   Google Scholar
• Merlis J. K. The effects of changes in the calcium content of the cerebrospinal fluid on spinal reflex activity in the dog. Am. J. Physiol. 1940; 13: 71
   Google Scholar
• O'Brien M. D., Jordan M. M., Waltz A. G. Ischemic cerebral edema and the blood brain barrier. Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery. Arch. Neurol. 1974; 30: 461
   PubMed Web of Science ®Google Scholar
• Petito C. K., Cash K. S. Blood brain abnormalities in the acquired immunodeficiency syndrome. Immunohisto chemical localization of serum proteins in postmortem brain. Ann. Neurol. 1992; 32: 658
   PubMed Web of Science ®Google Scholar
• Pirovano G., Lorusso V., Tirone P., Rosati G. Tolerance and pharmacokinetic evaluation of Gd-BOPTA/dimeg at high doses in healthy volunteers. J. Magn. Reson. Imaging 1993; 3 (P): 155
   Google Scholar
• Preston E., Allen M., Haas N. A modified method for measurement of radiotracer permeation across the rat blood-brain barrier. the problem of correcting brain up take for intravascular tracer. J. Neurosci. Meth. 1983; 9: 45
   PubMed Web of Science ®Google Scholar
• Preston E., Butler K., Haas N. Does magnetic resonance imaging compromise integrity of the blood-brain barrier?. Neurosci. Lett. 1989; 101: 46
   PubMed Web of Science ®Google Scholar
• Rapoport S. I. Sites and functions of the blood-brain barrier. Blood-brain barrier in physiology and medicine, chapter 3. Raven Press, New York 1976; 43
   Google Scholar
• Rapoport S. I., Thomson H. K. Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits. Science 1973; 180: 971
   PubMed Web of Science ®Google Scholar
• Roman-Goldstein S., Clunie D. A., Stevens J., et al. Osmotic blood-brain barrier disruption. CT and radionuclide imaging. AJNR 1994; 15: 581
   PubMed Web of Science ®Google Scholar
• Rosati G., Pirovano G., Spinazzi A. Interim results of phase II clinical testing of gadobenate dimeglumine (Gadobenate). Invest. Radiol. 1994; 29(Suppl. 2)S183
   PubMed Web of Science ®Google Scholar
• Schmiedl U. P., Kenney J., Maravilla K. R. Kinetics of pathologic blood-brain barrier permeability in an astrocytic glioma using contrast-enhanced MR. AJNR 1992; 13: 5
   PubMed Web of Science ®Google Scholar
• Scialfa G., Belloni G., Dalla Palma L., et al. Safety and efficacy of gadobenate dimeglumine (gd-bopt/dimeg) in MRI of intracranial tumors. Neuroradiology 1993; 35(Suppl.)551
   PubMed Web of Science ®Google Scholar
• Tallarida R. J., Murray R. B. Manual of pharmacologic calculations with computer programs. Springer, New York 1986
   Google Scholar
• Uggeri F, Aime S., Anelli P. L., et al. Novel contrast agents for magnetic resonance imaging. Synthesis and characterization of the ligand BOPTA and its Ln(III) complexes (Ln = Gd, La, Lu). X-ray structure of disodium (TPS-9–145337286-C-S)-[4-carboxy-5,8,11-tris(ca boxymethyl)- 1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5−)] gadolinate(2−) in a mixture with its enantiomer. Inorg. Chem. 1995; 34: 633
   Web of Science ®Google Scholar
• Vittadini G., Felder E., Tirone P., Lorusso V. B-19036, a potential new hepatobiliary contrast agent for MR proton imaging. Invest. Radiol. 1988; 23: S246
   PubMed Web of Science ®Google Scholar
• Vogl T. J., Pegios W., McMahon C., et al. Gadobenate dimeglumine, a new agent for MR imaging. Preliminary evaluation in healthy volunteers. AJR 1992; 158: 887
   PubMed Web of Science ®Google Scholar